Corbus Pharmaceuticals Q4 Earnings Summary & Key Takeaways

Corbus Pharmaceuticals (NASDAQ:CRBP) announced its Q4 earnings on Monday, March 9, 2026 at 07:30 AM.

Here's a breakdown of the earnings report.

Earnings

Corbus Pharmaceuticals beat estimated earnings by 24.7%, reporting an EPS of $-1.25 versus an estimate of $-1.66.

Revenue was down $0 from the same period last year.

Overview of Past Earnings

The company missed on EPS by $0.16 in the last quarter, resulting in a 1.07% drop share price change the following day.

To track all earnings releases for Corbus Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.